PriceTargets.com logo

Acadia Healthcare - ACHC Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $91.22
  • Forecasted Upside: 30.02%
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$70.16 As of 04/19/2024 01:00 AM ET
▼ -0.12 (-0.17%)

This chart shows the closing price for ACHC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Acadia Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACHC

Analyst Price Target is $91.22
▲ +30.02% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Acadia Healthcare in the last 3 months. The average price target is $91.22, with a high forecast of $102.00 and a low forecast of $63.00. The average price target represents a 30.02% upside from the last price of $70.16.

This chart shows the closing price for ACHC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 8 investment analysts is to moderate buy stock in Acadia Healthcare. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/6/2024MizuhoBoost TargetNeutral ➝ Neutral$77.00 ➝ $84.00Low
3/6/2024BarclaysInitiated CoverageOverweight$100.00Low
3/5/2024Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$90.00Low
3/4/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$94.00Low
3/1/2024TD CowenBoost TargetOutperform ➝ Outperform$86.00 ➝ $101.00Low
2/28/2024UBS GroupBoost TargetBuy ➝ Buy$88.00 ➝ $102.00Low
1/5/2024StephensUpgradeEqual Weight ➝ Overweight$92.00Low
11/7/2023Royal Bank of CanadaLower TargetOutperform ➝ Outperform$99.00 ➝ $94.00Low
9/14/2023Cantor FitzgeraldBoost TargetNeutral ➝ Neutral$83.00 ➝ $85.00Low
7/31/2023Royal Bank of CanadaBoost TargetOutperform$93.00 ➝ $99.00Low
5/4/2023Credit Suisse GroupBoost Target$95.00Low
4/20/2023Cantor FitzgeraldInitiated CoverageNeutral$83.00Low
4/20/2023Deutsche Bank AktiengesellschaftDowngradeHold ➝ Sell$75.00 ➝ $63.00Low
3/6/2023Deutsche Bank AktiengesellschaftLower TargetHold$82.00 ➝ $75.00Low
3/6/2023MizuhoLower TargetNeutral$87.00 ➝ $80.00Low
3/1/2023StephensLower TargetEqual Weight$92.00 ➝ $88.00Low
2/28/2023StephensReiterated RatingEqual Weight$92.00Low
12/12/2022Royal Bank of CanadaLower TargetOutperform$94.00 ➝ $93.00Low
12/12/2022Loop CapitalUpgradeHold ➝ Buy$90.00 ➝ $95.00Low
12/8/2022StephensBoost TargetEqual Weight$86.00 ➝ $88.00Low
12/8/2022MizuhoBoost TargetNeutral$80.00 ➝ $87.00Low
11/4/2022UBS GroupLower Target$96.00Low
11/2/2022StephensBoost TargetEqual Weight$85.00 ➝ $86.00Low
11/2/2022MizuhoBoost TargetNeutral$78.00 ➝ $80.00Low
8/26/2022SVB LeerinkBoost TargetOutperform ➝ Outperform$95.00 ➝ $103.00Low
8/1/2022Deutsche Bank AktiengesellschaftBoost Target$70.00 ➝ $82.00Low
7/28/2022UBS GroupBoost TargetBuy$82.00 ➝ $90.00Low
7/28/2022Jefferies Financial GroupBoost Target$85.00 ➝ $95.00Low
6/20/2022UBS GroupSet Target$82.00Low
6/16/2022Loop CapitalInitiated CoverageHold$72.00Medium
5/6/2022BMO Capital MarketsBoost Target$67.00 ➝ $82.00Low
5/4/2022MizuhoBoost Target$64.00 ➝ $69.00High
4/8/2022SVB LeerinkBoost TargetOutperform$80.00 ➝ $90.00High
3/2/2022Credit Suisse GroupBoost TargetOutperform$74.00 ➝ $78.00Medium
3/1/2022SVB LeerinkLower TargetOutperform$83.00 ➝ $80.00High
11/1/2021Credit Suisse GroupBoost TargetOutperform$68.00 ➝ $69.00Medium
9/27/2021SVB LeerinkInitiated CoverageOutperform$85.00Low
9/23/2021UBS GroupInitiated CoverageBuy$81.00Low
9/20/2021Credit Suisse GroupUpgradeNeutral ➝ Outperform$68.00High
9/9/2021CowenInitiated CoverageOutperform$79.00Medium
8/12/2021BarclaysInitiated CoverageUnderweight$69.00Low
8/4/2021Credit Suisse GroupBoost TargetNeutral$60.00 ➝ $68.00Medium
8/4/2021Deutsche Bank AktiengesellschaftBoost TargetHold$62.00 ➝ $70.00Medium
8/4/2021CitigroupBoost TargetBuy$73.00 ➝ $77.00Medium
7/9/2021Seaport Res PtnReiterated RatingNeutralHigh
5/3/2021CitigroupBoost Target$65.00 ➝ $73.00Low
5/3/2021Credit Suisse GroupBoost TargetNeutral$56.00 ➝ $60.00Medium
5/3/2021Raymond JamesBoost TargetStrong-Buy$65.00 ➝ $70.00High
4/30/2021MizuhoBoost TargetNeutral$53.00 ➝ $62.00Medium
4/19/2021Deutsche Bank AktiengesellschaftBoost TargetHold$55.00 ➝ $62.00High
3/1/2021Credit Suisse GroupBoost TargetNeutral$54.00 ➝ $56.00N/A
3/1/2021Raymond JamesBoost TargetStrong-Buy$48.00 ➝ $65.00Low
3/1/2021MizuhoBoost TargetNeutral$50.00 ➝ $53.00Low
12/31/2020Robert W. BairdReiterated RatingNeutralN/A
12/31/2020Credit Suisse GroupBoost Target$36.00 ➝ $44.00N/A
12/30/2020Jefferies Financial GroupBoost TargetSell ➝ Buy$44.00 ➝ $60.00N/A
12/18/2020MizuhoBoost TargetNeutral$35.00 ➝ $50.00High
11/17/2020UBS GroupUpgradeNeutral ➝ Buy$37.00 ➝ $54.00Medium
11/2/2020StephensBoost TargetPositive ➝ Equal Weight$33.00 ➝ $42.00Medium
11/2/2020Credit Suisse GroupBoost TargetNeutral$32.00 ➝ $36.00Low
11/2/2020MizuhoBoost TargetBuy$31.00 ➝ $35.00Low
11/2/2020Royal Bank of CanadaBoost TargetOutperform$37.00 ➝ $42.00Low
9/30/2020Raymond JamesUpgradeOutperform ➝ Strong-Buy$40.00 ➝ $48.00Low
9/11/2020Raymond JamesReiterated RatingBuyLow
8/6/2020Credit Suisse GroupBoost TargetNeutral$28.00 ➝ $32.00Low
8/6/2020Deutsche Bank AktiengesellschaftBoost TargetHold$28.00 ➝ $32.00Low
8/6/2020MizuhoBoost TargetNeutral$26.00 ➝ $31.00Low
5/7/2020Deutsche Bank AktiengesellschaftLower TargetHold$32.00 ➝ $28.00Medium
5/6/2020Robert W. BairdLower TargetNeutral$36.00 ➝ $30.00High
5/6/2020Credit Suisse GroupLower TargetNeutral$33.00 ➝ $28.00High
5/6/2020MizuhoBoost TargetNeutral$24.00 ➝ $26.00High
5/6/2020Raymond JamesLower TargetOutperform$40.00 ➝ $35.00High
5/5/2020Wells Fargo & CompanyReiterated RatingHoldHigh
1/28/2020StephensInitiated CoverageEqual Weight$36.00Low
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$27.00Low
12/11/2019Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$37.00 ➝ $35.00Medium
10/10/2019Jefferies Financial GroupSet TargetBuy$40.00Low
9/20/2019UBS GroupBoost TargetNeutral$29.00 ➝ $34.00Medium
9/6/2019UBS GroupLower TargetNeutral$30.00 ➝ $29.00N/A
7/31/2019Raymond JamesDowngradeStrong-Buy ➝ Outperform$45.00High
5/31/2019MizuhoSet TargetHold$30.00Medium
5/2/2019Deutsche Bank AktiengesellschaftSet TargetHold$32.00Low
5/1/2019BMO Capital MarketsBoost TargetMarket Perform ➝ Market Perform$33.00 ➝ $36.00High
(Data available from 4/19/2019 forward)

News Sentiment Rating

0.60 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 12 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 9 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 7 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 10 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 8 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2024
  • 12 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 19 very positive mentions
  • 24 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 8 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 8 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Acadia Healthcare logo
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Read More

Today's Range

Now: $70.16
Low: $69.74
High: $70.73

50 Day Range

MA: $79.18
Low: $70.16
High: $87.38

52 Week Range

Now: $70.16
Low: $66.49
High: $87.77

Volume

399,420 shs

Average Volume

561,686 shs

Market Capitalization

$6.48 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31

Frequently Asked Questions

What sell-side analysts currently cover shares of Acadia Healthcare?

The following equities research analysts have issued reports on Acadia Healthcare in the last year: Barclays PLC, Cantor Fitzgerald, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Mizuho, Royal Bank of Canada, Stephens, StockNews.com, TD Cowen, TheStreet, and UBS Group AG.
View the latest analyst ratings for ACHC.

What is the current price target for Acadia Healthcare?

9 Wall Street analysts have set twelve-month price targets for Acadia Healthcare in the last year. Their average twelve-month price target is $91.22, suggesting a possible upside of 30.0%. UBS Group AG has the highest price target set, predicting ACHC will reach $102.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $63.00 for Acadia Healthcare in the next year.
View the latest price targets for ACHC.

What is the current consensus analyst rating for Acadia Healthcare?

Acadia Healthcare currently has 1 sell rating, 2 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for ACHC.

What other companies compete with Acadia Healthcare?

Other companies that are similar to Acadia Healthcare include The Ensign Group, Inspire Medical Systems, Elanco Animal Health, DENTSPLY SIRONA and Vaxcyte. Learn More about companies similar to Acadia Healthcare.

How do I contact Acadia Healthcare's investor relations team?

Acadia Healthcare's physical mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The company's listed phone number is (615) 861-6000. The official website for Acadia Healthcare is www.acadiahealthcare.com. Learn More about contacing Acadia Healthcare investor relations.